期 |
标题 |
文件 |
卷 95, 编号 4 (2023) |
Congratulations from the editors of The Therapeutic Archive |
(Rus)
|
Board E.
|
卷 92, 编号 12 (2020) |
Mixed steatohepatitis: more questions than answers (Part 1) |
(Rus)
|
Raikhelson K., Kondrashina E., Pazenko E.
|
卷 92, 编号 12 (2020) |
Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma |
(Rus)
|
Zyryanov S., Avdeev S., Ivanov D., Zhuravleva M., Kniajeskaia N., Matveev N., Nenasheva N., Fomina D., Frolov M.
|
卷 92, 编号 12 (2020) |
Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease |
(Rus)
|
Vakhrushev Y., Suchkova E., Lukashevich А.
|
卷 92, 编号 12 (2020) |
Rebamipide: evidence base for use in gastroenterology |
(Rus)
|
Andreev D., Maev I.
|
卷 92, 编号 12 (2020) |
Clinical case of combined genetic pathology in a patient |
(Rus)
|
Losik E., Yakushina I., Skhirtladze M., Balahonova N., Kerchev V., Garanina I.
|
卷 92, 编号 12 (2020) |
Resected bowel syndrome: clinical course and treatment options |
(Rus)
|
Hatkov I., Kuzmina T., Sabelnikova E., Parfenov A.
|
卷 92, 编号 12 (2020) |
Recommendations for the Protocol of functional examination of the anorectal zone and disorders classification: the International Anorectal Physiology Working Group consensus and Russian real-world practice |
(Rus)
|
Fomenko O., Morozov S., Scott S., Knowles H., Morozov D., Shelygin Y., Maev I., Nikityuk D., Shkoda A., Kashnikov V., Bordin D., Isakov V., Biryukov O., Belousova S., Pimenova E., Rumiantsev A., Fedorov E., Gvozdev M., Trukhmanov A., Storonova O., Indeykina L., Biryukova M., Andreev D., Kucheryavyy Y., Achkasov S.
|
卷 92, 编号 12 (2020) |
Adrenal incidentaloma. Part 1. Computed tomography of adrenal incidentaloma: the possibilities and difficulties of differential diagnosis |
(Rus)
|
Buryakina S., Tarbaeva N., Volevodz N., Karmazanovsky G., Kovalevich L., Shestakova M., Dedov I.
|
卷 92, 编号 12 (2020) |
The prevalence of sarcopenia in patients with chronic pancreatitis: a meta-analysis |
(Rus)
|
Maev I., Andreev D., Kucheryavyy Y., Levchenko A.
|
卷 92, 编号 12 (2020) |
Autoimmunity and autoinflammation in pathogenesis of immunoinflammatory diseases |
(Rus)
|
Shilkina N., Masina I., Dryazhenkova I., Vinogradov A., Yunonin I.
|
卷 92, 编号 12 (2020) |
BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic |
(Rus)
|
Kalyuzhin O., Andronova T., Karaulov A.
|
卷 92, 编号 12 (2020) |
Anemia as a risk factor of contrast-associated acute kidney injury |
(Rus)
|
Mironova O., Deev A., Lakotka P., Fomin V.
|
卷 92, 编号 12 (2020) |
The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases |
(Rus)
|
Vasil'ev V., Chal'tsev B., Gorodetskii V., Pal'shina S., Shornikova N., Anan'eva L., Gaiduk I., Kokosadze N., Probatova N., Pavlovskaia A., Rodionova E., Safonova T., Balabina A.
|
卷 92, 编号 12 (2020) |
Insulin therapy is a personalized approach to glycemic management in diabetes |
(Rus)
|
Demidova T., Titova V.
|
卷 92, 编号 12 (2020) |
Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis |
(Rus)
|
Kucheryavyy Y., Andreev D., Maev I.
|
卷 92, 编号 12 (2020) |
Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation |
(Rus)
|
Allazova S., Novikova M., Kotenko O., Shilov E.
|
卷 92, 编号 12 (2020) |
Diagnosis of thrombotic thrombocytopenic purpura |
(Rus)
|
Galstyan G., Klebanova E.
|
卷 92, 编号 12 (2020) |
Testing and validation of the Russian version of quality of life questionnaire in patients with GERD – GERD-HRQL |
(Rus)
|
Ionova T., Zinkovskaya A., Mayevskaya E., Nikitina T., Porfirieva N., Cheremushkina N., Shaburov R., Kucheryavyy Y., Maev I.
|
卷 92, 编号 12 (2020) |
Comparative capabilities of the speckle-tracking echocardiography technologiesin two-dimensional and three-dimensional modes in the detection of subclinical cardiotoxicity in patients with breast cancer |
(Rus)
|
Saidova M., Avalyan A., Oshchepkova E., Shitov V., Chazova I.
|
卷 92, 编号 12 (2020) |
Vascular remodeling with violations of intracardiac hemodynamics in patients older age category, combined with the clinical-cluster, neurocognitive and biomarker heterogeneity in multifocal atherosclerosis |
(Rus)
|
Khasanov A., Bakirov B., Davletshi R., Novikova L., Kudlay D.
|
卷 92, 编号 12 (2020) |
Experience of olokizumab use in COVID-19 patients |
(Rus)
|
Antonov V., Ignatova G., Pribytkova O., Sleptsova S., Strebkova E., Khudyakova E., Simakov A., Rabets S., Tikhonova E., Kurmaeva D., Petrushin M., Mashkov A., Gayazova E., Yasheva I., Andreev M., Khinovker V., Karpunin A., Berezhanskiy B.
|
卷 92, 编号 12 (2020) |
Chronic intestinal pseudo-obstruction |
(Rus)
|
Parfenov A., Krums L., Bykova S., Ahmadullina O.
|
卷 92, 编号 12 (2020) |
Antiresorptive activity of pharmacological chondroitin sulfate in the older age group |
(Rus)
|
Shavlovskaya O., Zolotovskaya I., Prokofyeva Y.
|
卷 92, 编号 12 (2020) |
Evaluation of the clinical efficacy of local antibacterial therapy in the treatment of acute bacterial rhinosinusitis |
(Rus)
|
Banashek-Meshcheriakova T., Semyonov F.
|
卷 92, 编号 12 (2020) |
Pericarditis in contemporary therapeutic clinic: nosological spectrum, approaches to diagnosis and treatment |
(Rus)
|
Blagova O., Nedostup A., Sedov V., Kogan E., Alijeva I., Sorokin G., Sarkisova N.
|
卷 92, 编号 12 (2020) |
Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia |
(Rus)
|
Shmalts A., Gorbachevsky S.
|
卷 92, 编号 12 (2020) |
The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection |
(Rus)
|
Lioznov D., Tokin I., Zubkova T., Sorokin P.
|
卷 92, 编号 12 (2020) |
Detection of kidney dysfunction potential biomarkers with hypertension in the persons of 25–45 years |
(Rus)
|
Kovalkova N., Khudyakova A., Kashtanova E., Polonskaya Y., Shcherbakova L., Ragino Y.
|
卷 92, 编号 12 (2020) |
Diagnosis and treatment of hereditary angioedema with normal C1-inhibitor level |
(Rus)
|
Emelyanov A., Leshenkova E., Kameneva G.
|
卷 92, 编号 12 (2020) |
Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе |
(Rus)
|
Khokhlov A., Mariandyshev A., Shcherbakova V., Ozerova I., Kazaishvili Y., Igumnova O., Bolgarina A., Rudoy B.
|
卷 92, 编号 12 (2020) |
Association of rs3025058 polymorphism with the development of stroke in patients with cardiovascular pathology |
(Rus)
|
Nikulina S., Shulman V., Chernova A., Prokopenko S., Nikulin D., Platunova I., Tretyakova S., Semenchukov A., Marilovtseva O., Lebedeva I., Maksimov V., Gurazheva A.
|
卷 91, 编号 6 (2019) |
The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works |
(Rus)
|
Shakhnovich R., Ruda M.
|
卷 91, 编号 6 (2019) |
Difficulties in diagnosing the syndrome of "aorto - mesenteric tweezers" (nutcracker syndrome) in a patient with macrogematuria |
(Rus)
|
Grigoryeva E., Senichkina M., Maiorova A., Kiseleva O.
|
卷 91, 编号 6 (2019) |
Burden, access, and disparities in kidney disease |
(Rus)
|
Crews D., Bello A., Saadi G.
|
卷 91, 编号 6 (2019) |
Atrial myocarditis in a patient with Takayasu arteritis |
(Rus)
|
Safiullina A., Uskach T., Zhirov I., Pogorelova O., Stukalova O., Gaman S., Gramovich V., Novikov P., Tereshchenko S.
|
卷 91, 编号 6 (2019) |
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease |
(Rus)
|
Moiseev S., Karovaikina E., Bulanov N., Moiseev A., Fomin V.
|
卷 91, 编号 6 (2019) |
Chronic kidney disease in the context of toxic effects the working chemical factors (literature review) |
(Rus)
|
Strizhakov L., Fomin V., Garipova R., Babanov S., Arkhipov E., Lebedeva M.
|
卷 91, 编号 6 (2019) |
Low protein diet with essential amino acids ketoanalogues combination can affect serum FGF-23 and Klotho levels in chronic kidney disease 3b-4 stages patients: randomized pilot study |
(Rus)
|
Milovanova L., Kozlovskaya(Lysenko) L., Androsova T., Lebedeva M., Taranova M., Milovanova S., Kondratyeva T., Zubacheva D., Tchebotareva N., Kozlov V., Kuchieva A., Li O., Reshetnikov V.
|
卷 91, 编号 6 (2019) |
Modern approaches to conservative therapy of polycystic kidney disease |
(Rus)
|
Rudenko T., Bobkova I., Stavrovskaya E.
|
卷 91, 编号 6 (2019) |
Clinical and pathologic features of nephropathy with C1q deposits |
(Rus)
|
Chebotareva N., Vinogradov A., Grishina A., Kozlovskaya(Lysenko) L., Varshavsky V.
|
卷 91, 编号 6 (2019) |
Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment |
(Rus)
|
Milovanova S., Kozlovskaya(Lysenko) L., Milovanova L., Gordovskaya N., Ignatova T., Taranova M., Androsova T.
|
卷 91, 编号 6 (2019) |
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease |
(Rus)
|
Bolotova E., Dudnikova A.
|
卷 91, 编号 6 (2019) |
Circulating microRNAs as potential biomarkers of chronic kidney disease |
(Rus)
|
Aitbaev K., Murkamilov I., Fomin V.
|
卷 91, 编号 6 (2019) |
Modern approaches to the detection of monoclonal gammopathy of undetermined significance (MGUS) in patients with kidney diseases |
(Rus)
|
Kozlovskaya(Lysenko) L., Chebotareva N., Mrykhin N., Rameev V., Androsova T., Roshchupkina S., Maryina S., Kogarko I., Kogarko B.
|
卷 91, 编号 6 (2019) |
Diagnosis and treatment of myocardial infarction in patient with end - stage renal disease on chronic hemodialysis |
(Rus)
|
Antukh D., Shchekochikhin D., Nesterov A., Gilarov M.
|
卷 91, 编号 6 (2019) |
Russian Therapeutic School: D.D. Pletnev, A.L. Myasnikov, E.I. Chazov |
(Rus)
|
Chuchalin A.
|
卷 91, 编号 6 (2019) |
Polyvascular disease in patients with myocardial infarction and chronic kidney disease |
(Rus)
|
Karetnikova V., Kalaeva V., Evseeva M., Gruzdeva O., Zykov M., Kashtalap V., Barbarash O.
|
卷 91, 编号 6 (2019) |
Academician E.I. Chazov’s contribution to cardiology |
(Rus)
|
Oschepkova E.
|
卷 91, 编号 6 (2019) |
Protein - energy wasting of haemodialysis patients |
(Rus)
|
Jakovenko A., Rumyantsev A.
|
1 - 50 的 54 信息 |
1 2 > >>
|